MRI tenosynovitis plus ultrasound erosions identifies who will develop arthritis

Design

prospective cohort with contemporaneous contrast-enhanced 3T MRI and 36-joint ultrasound, Cox regression

Population

130 anti-CCP-positive individuals with musculoskeletal symptoms and no clinical synovitis, median follow-up 36.5 months

Primary outcome

progression to inflammatory arthritis

Effect

48 of 130 (36.9%) progressed; MRI hand tenosynovitis and ultrasound bone erosions independently predictive; both features together hazard ratio 5.83

One hundred and thirty anti-CCP-positive individuals with musculoskeletal symptoms but no clinical synovitis had contrast-enhanced 3T MRI of the dominant or most symptomatic hand and both feet, scored by a rheumatologist and a radiologist using RAMRIS, plus ultrasound of 36 joints and 18 tendons. They were followed for a median 36.5 months.

Two baseline findings stand out. First, every single participant had at least one RAMRIS abnormality — including those whose ultrasound was completely normal — while ultrasound found abnormalities in only 25.4 per cent. A sensitive test on which nobody is negative carries no discriminating information on its own. Second, 48 of 130 (36.9 per cent) progressed to inflammatory arthritis, and within all that MRI signal only hand tenosynovitis predicted progression consistently across both binary and continuous analyses. On ultrasound, bone erosions were the most consistently predictive feature. Having both carried a hazard ratio of 5.83.

So the two modalities do different jobs, and the useful protocol is not 'scan more' but 'scan for these two things'. The authors are explicit that the feasibility and cost-effectiveness of doing both contrast-enhanced hand MRI and an extensive ultrasound protocol still need evaluation — and in most settings, including Indian practice, contrast MRI of the hand in an asymptomatic-on-examination patient is not a realistic default. The transferable part is the ultrasound half: erosions at a focused examination, in a CCP-positive patient without synovitis, should shorten the follow-up interval and start the conversation about what happens next.

• In CCP-positive at-risk patients, look for tenosynovitis and erosions specifically, not general inflammation
• Do not treat a normal ultrasound as reassurance — every patient here had MRI abnormalities
• Shorten review intervals where erosions are found on ultrasound
• Where MRI is available, hand tenosynovitis is the feature worth reporting, not the total RAMRIS score
• Quote a roughly one in three three-year progression risk when counselling this group

Why it matters

It tells you which of the many imaging abnormalities in this group actually predicts anything.

Don't overread it

A single prospective cohort of 130 — the combined MRI and ultrasound protocol has not been shown to be feasible or cost-effective, and no treatment decision has been tested against it.

The statistics, in plain English

That every participant had an MRI abnormality is the key statistic: a finding present in 100 per cent of a cohort cannot separate progressors from non-progressors, however sensitive it is. The hazard ratio of 5.83 for having both features comes from a subgroup within 130 people and 48 events, so the point estimate is unstable even though the direction is well supported.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.